Zobrazeno 1 - 10
of 148
pro vyhledávání: '"L. Demidov"'
Autor:
K. E. Aronson, A. Yu. Ryabchikov, N. V. Zhelonkin, D. V. Brezgin, A. L. Demidov, D. Yu. Balakin
Publikováno v:
Thermal Engineering. 70:245-253
Publikováno v:
Thermal Engineering. 69:785-791
Autor:
C. Robert, K.D. Lewis, R. Gutzmer, D. Stroyakovskiy, H. Gogas, S. Protsenko, R.P. Pereira, T. Eigentler, P. Rutkowski, L. Demidov, I. Caro, H. Forbes, K. Shah, Y. Yan, H. Li, G.A. McArthur, P.A. Ascierto
Publikováno v:
Annals of Oncology. 33:544-555
Publikováno v:
Bulletin of KSAU. :163-168
Publikováno v:
Bulletin of KSAU. :225-231
Publikováno v:
Vestnik oftalmologii. 137(5. Vyp. 2)
Studying the possibilities of hybrid (femtosecond laser-assisted) phacoemulsification in complicated situations is a relevant problem in cataract surgery.To develop a technique for hybrid (femtosecond laser-assisted) phacoemulsification in patients w
Autor:
Abraham Anderson, John R. Hyngstrom, Robert M. Conry, L. Demidov, Hoi-Shen Radcliffe, David E. Gyorki, Sheryl Treichel, Merrick I. Ross, Reinhard Dummer, Adam C. Berger, Anjali Sharma, Kevin S. Gorski, Mark B. Faries, Edward Chan
Talimogene laherparepvec (T-VEC) is a herpes simplex virus type 1-based intralesional oncolytic immunotherapy approved for the treatment of unresectable melanoma. The present, ongoing study aimed to estimate the treatment effect of neoadjuvant T-VEC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a43b3fbc2256dc5161d01215a49992b
https://doi.org/10.5167/uzh-207019
https://doi.org/10.5167/uzh-207019
Autor:
C, Robert, K D, Lewis, R, Gutzmer, D, Stroyakovskiy, H, Gogas, S, Protsenko, R P, Pereira, T, Eigentler, P, Rutkowski, L, Demidov, I, Caro, H, Forbes, K, Shah, Y, Yan, H, Li, G A, McArthur, P A, Ascierto
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 33(5)
The phase III IMspire150 study (NCT02908672) demonstrated significantly improved progression-free survival (PFS) with atezolizumab, vemurafenib, and cobimetinib (atezolizumab group) versus placebo, vemurafenib, and cobimetinib (control group) in pati
Autor:
M. Del Vecchio, V.G. Atkinson, B. Ryll, A.M. Menzies, F. Aubin, V. Chiarion Sileni, V. Ferraresi, T. Lesimple, G. Rinaldi, P. Saiag, C. Robert, C. Dutriaux, H.J. Gogas, L. Demidov, A. Gupta, H. Banerjee, S. Sudhir, F. Miranda, M.R. Lau, J.J. Grob
Publikováno v:
Annals of Oncology. 33:S914
Autor:
R. Dummer, D. Gyorki, J. Hyngstrom, A. Berger, R. Conry, L. Demidov, L. Ning, T. Lawrence, M. Faries, M. Ross
Publikováno v:
Annals of Oncology. 33:S1406